RecruitingNCT06761196

Quality of Life After Breast Cancer Surgery

Assessing Quality of Life After Breast Cancer Surgery: a Prospective Cohort Study


Sponsor

Centre Hospitalier de Colmar

Enrollment

1,500 participants

Start Date

Sep 2, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to prospectively collect data on quality of life after oncoplastic breast surgery. Participants will be followed-up and answer quality of life questionnaire for a duration of 5 years after surgery.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Patient aged 18 or over
  • Patient with breast cancer of any stage (including in situ) or healthy individual at high personal risk.
  • Patient requiring breast surgery under general anesthesia, whether for therapeutic or prophylactic purposes.
  • Patient capable, in the opinion of the investigator, of complying with the requirements and restrictions of the study.
  • Patient with a computer, tablet or smartphone connected to the Internet.
  • Patient followed in the center on a regular basis according to standard recommendations.

Exclusion Criteria5

  • Patient requiring surgical intervention under local anesthesia only.
  • Patient requiring surgery for the installation or removal of an chemotherapy implantable port only.
  • Patients with a history of cancer other than breast cancer. Patients with a history of cancer more than three years old are eligible if they are treated and considered cured. Patients with a history of cervical carcinoma in situ or non-melanoma skin carcinoma are eligible.
  • Impossibility of being subject to regular monitoring for geographical, social or psychological reasons.
  • Patient under protective measure

Interventions

OTHERQuestionnaire

The quality of life measured with different scales (BREAST-Q, EORTC QLQ C30 and BR42)


Locations(1)

Hôpitaux Civils de Colmar

Colmar, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06761196


Related Trials